Trial record 1 of 1 for:    Phase II Abiraterone Acetate Treatment for Prostate Cancer Patients with PSA of More Than Four Following Initial Androgen Deprivation Therapy
Previous Study | Return to List | Next Study

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Southwest Oncology Group
ClinicalTrials.gov Identifier:
NCT01309672
First received: March 4, 2011
Last updated: December 2, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)